April 26, 2021
virtuell zoom
Europe/Zurich timezone

More than 300 participants from all over the world
(more than 40 countries) attended the symposia

Event Programme

 

Moderated by M. van Daalen

 

Prof. Dr. C. Rüegg (Director of PSI)

Opening Remarks

08.30

 Prof. Dr. R. Schibli

Chair

08.45

Dr. N. van der Meulen

TATTOOS – project plans at PSI

08.50 (20 + 5 min questions)

Prof. Michael Hofman

(Peter MacCallum Cancer Centre, Melbourne, Australia)

A new Era of Treating Prostate Cancer: Improving Outcomes with Theranostics

09.15 (20 min + 5 min questions)

Prof. Dr. Richard Baum

(CURANOSTICUM Wiesbaden-Frankfurt, Germany)

“From innovation to implementation: Advancing Radiomolecular Precision Oncology (RPO) by novel radiosiotopes for Theranostics of Personalized Cancer Care”

09.40 (20 min + 5 min questions)

 

Short break

10.05 min

PD Dr. C. Müller

Chair

10.15

Prof. Dr. George Thalmann

(Inselspital,Bern, Bern, Switzerland)

Theranostics in prostate cancer: the urologists view of unmet needs and hopes

10.40 (20 min + 5 min

questions)

Prof. Dr. Damian Wild

(University Hospital Basel, Basel Switzerland)

Theranostics in Neuroendocrine Neoplasia (NEN) – new Treatment Options

11.05 (20 min + 5 min questions)

Dr. Ulli Köster

(Institut Laue-Langevin, Grenoble, France)

Production of emerging radionuclides

11.30 (20 + 5 min question)s

 

Short break

11.55

Prof. Dr. R. Schibli

Round Table Discussion (Q&A Session)

with:

- Directorate, invited Speakers, representative of LRC, representative of CRS, invited Medical Doctors, representatives of industry

12.05 (45 min)

 

Break

 

 

Closing remarks

13.00

 

Starts
Ends
Europe/Zurich
virtuell zoom